논문KCI 등재
HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Selftesting strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (9)
관련 논문AI추천
Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea: Editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”Eun Sun Jang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectivenessBeom Kyung Kim, Gyeongseon Shin, Hankil Lee, Sang Hoon Ahn, SeungJin Bae대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Elimination of hepatitis C: What would be the practical approach?Hyung Joon Yim대한간학회 · Clinical and Molecular Hepatology2021 · 제27권 제1호Correspondence on Letter regarding “Toward hepatitis C virus elimination using artificial intelligence”Ming-Lung Yu, Ming-Ying Lu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호How to Optimize the Care Cascade of Hepatitis C Virus InfectionKim Beom Kyung거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제6호Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy김도영거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제6호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133